Rover Diagnostics
Mark Fasciano is the Co-Founder and CEO of various companies such as Rover Labs, Rover Diagnostics, Clarapath, and FatWire Software. He has a background in Computer Science and Artificial Intelligence, with a BA from Cornell University and a PhD from the University of Chicago. Throughout his career, Mark has been involved in the development of innovative technologies in various fields such as diagnostics, biotechnology, and natural language processing.
This person is not in any teams
Rover Diagnostics
Rover Diagnostics was founded in 2018 by Samuel Sia and Mark Fasciano in collaboration with Columbia University. Based in New York City, Rover’s primary mission is to help meet the urgent global need for a cost-effective, highly sensitive, mass-produced point-of-care COVID-19 instrument and test kit system. Rover is a participant in the NIH RADx program to accelerate availability and capacity for COVID testing.